Global Mammography Market

Global Mammography Market Size, Share, Growth Analysis, By Product(film screen systems, digital systems), By end use(hospitals, speciality clinics), By technology(breast tomosynthesis, CAD mammography) - Industry Forecast 2024-2031


Report ID: SQMIG35G2133 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 90 | Figures: 76

Global Mammography Market News

  • In May 2022, At the SBI/ACR Breast Imaging Symposium, Volpara Health unveiled upgraded solutions for its integrated platform for the provision of individualized breast care. The mammography quality and reporting, volumetric breast density measures, and cancer risk assessment are all provided by Volpara's AI-driven breast software solutions.
  • In January 2022, With the introduction of Transpara, an AI Breast Care system, ScreenPoint Medical grew its footprint in the US and in 30 other countries across the world.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Mammography Market size was valued at USD 2 million in 2019 and is poised to grow from USD 2.2 million in 2023 to USD 4.63 million by 2031, growing at a CAGR of 10.1% in the forecast period (2024-2031).

As there are only a few significant companies in the mammography business, it is a consolidated market. The top market competitors are concentrating on advancing technology and minimizing the negative impacts of operations. To sustain their position in the marketplace, industry participants are actively involved in a number of strategic activities. 'Hologic Inc.', 'Fujifilm Corporation', ' GE Healthcare ', ' Siemens Healthineers ', ' Koninklijke Philips N.V. ', ' Metaltronica S.p.A. ', ' Planmed Oy ', ' Carestream Health, Inc. ', ' BMI Biomedical International S.r.l. ', ' Allengers Medical Systems Ltd. ', ' General Medical Italia S.p.A. ', ' Amico JSC ', ' Delphinus Medical Technologies, Inc. ', ' Aurora Imaging Technology, Inc. ', ' CMR Naviscan Corporation ', ' Micrima Limited ', ' iCAD Inc. ', ' KUB Technologies Inc. ', ' Solis Mammography ', ' Siemens AG '

The market should improve due to the increase in elderly populations, proactive efforts by clinical consideration relationships to reveal problems with early signs of breast cancer growth, and an increase in the frequency of breast diseases. The demand for mammography equipment is also fueled by improved reimbursement policies, increased government funding for research into breast disease, and mechanical advancements like breast tomosynthesis, which makes it easier for women with dense breast tissue to recognize the development of breast cancer.

Many organizations have taken concrete steps to treat these infections since people with breast cancer are more likely to get the infection. According to a study by Dafina Petrova et al., which appeared in the September 2020 issue of Medicina Clnica Journal, the Spanish Society of Medical Oncology (SEOM), the Spanish Society of Radiation Oncology (SEOR), and the European Society for Medical Oncology (ESMO) have released some guidelines on how to modify treatment regimens in order to reduce risks for cancer patients. The updated regulations would offer more effective ways to conduct operations, which would enhance the therapies. The market for digital mammography is anticipated to expand in response to situations like these. Due to the better representation of low-contrast objects, wider dynamic change, and enhanced diagnostic quality of pictures, particularly when analyzing thicker breasts, the use of digital mammography is changing in an increasing number of nations.

With a revenue share of over 36.4% in 2021, North America led the world market and is predicted to rise at a significant rate throughout the forecast period. One of the main variables influencing the local market is the increasing prevalence of breast cancer. The American Cancer Society estimates that in 2020, there will be around 276,480 new cases of invasive breast cancer in women. In addition, it has been determined that 48,530 women have in situ breast cancer, and it is anticipated that this figure will increase in the upcoming years. Additionally, a lot of businesses have started to launch efforts to support breast cancer screenings.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Mammography Market

Product ID: SQMIG35G2133

$5,300
BUY NOW GET FREE SAMPLE